(Q37999699)

26 August 2017

title

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors (English)

1 reference

26 August 2017

Scott Kaatz

1

1 reference

26 August 2017

Peter A Kouides

2

1 reference

26 August 2017

David A Garcia

3

1 reference

26 August 2017

Alex C Spyropolous

4

1 reference

26 August 2017

Mark Crowther

5

1 reference

26 August 2017

Jim D Douketis

6

1 reference

26 August 2017

Anthony K C Chan

7

1 reference

26 August 2017

Andra James

8

1 reference

26 August 2017

Stephan Moll

9

1 reference

26 August 2017

Thomas L Ortel

10

1 reference

26 August 2017

Elizabeth M Van Cott

11

1 reference

26 August 2017

Jack Ansell

12

1 reference

26 August 2017

publication date

4 April 2012

1 reference

American Journal of Hematology

26 August 2017

published in

1 reference

26 August 2017

volume

87 Suppl 1

1 reference

26 August 2017

page(s)

S141-5

1 reference

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients

26 August 2017

cites work

1 reference

Apixaban with antiplatelet therapy after acute coronary syndrome

21 January 2018

1 reference

Rivaroxaban in patients with a recent acute coronary syndrome

21 January 2018

1 reference

New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

Prothrombin complex concentrate for critical bleeding

21 January 2018

1 reference

New antithrombotics: the impact on global health care

21 January 2018

1 reference

Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

21 January 2018

1 reference

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study

21 January 2018

1 reference

Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents

21 January 2018

1 reference

Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran

21 January 2018

1 reference

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.23202

1 reference

26 August 2017

1 reference